

| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $113K | -28.4% |
| Cost of Revenue | $45K | -56.0% |
| Gross Profit | $68K | +22.7% |
| R&D Expense | $24K | +127.6% |
| SG&A Expense | $319K | +98.2% |
| Operating Income | -$275K | -136.8% |
| Net Income | -$269K | -174.6% |
| EPS (Basic) | -$0.02 | -155.6% |
| EPS (Diluted) | -$0.02 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50K | -81.3% |
| Accounts Receivable | $11K | -77.6% |
| Current Assets | $70K | -78.4% |
| Total Assets | $70K | -78.4% |
| Current Liabilities | $425K | -0.2% |
| Total Liabilities | $425K | -0.2% |
| Stockholders' Equity | -$356K | -245.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$325K | — |
| Financing Cash Flow | $93K | +746.1% |
| -155.6% |